BR112014011741A2 - método de redução de dor nas articulações induzida pelo exercício em mamíferos não artríticos - Google Patents

método de redução de dor nas articulações induzida pelo exercício em mamíferos não artríticos

Info

Publication number
BR112014011741A2
BR112014011741A2 BR112014011741A BR112014011741A BR112014011741A2 BR 112014011741 A2 BR112014011741 A2 BR 112014011741A2 BR 112014011741 A BR112014011741 A BR 112014011741A BR 112014011741 A BR112014011741 A BR 112014011741A BR 112014011741 A2 BR112014011741 A2 BR 112014011741A2
Authority
BR
Brazil
Prior art keywords
exercise
reduction method
joint pain
pain reduction
induced joint
Prior art date
Application number
BR112014011741A
Other languages
English (en)
Portuguese (pt)
Inventor
C Lau Francis
Lugo James
Dijkstra Paul
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of BR112014011741A2 publication Critical patent/BR112014011741A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112014011741A 2013-10-24 2014-01-13 método de redução de dor nas articulações induzida pelo exercício em mamíferos não artríticos BR112014011741A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24
PCT/US2014/011303 WO2015060888A1 (en) 2013-10-24 2014-01-13 Method of reducing exercise-induced joint pain in non-arthritic mammals

Publications (1)

Publication Number Publication Date
BR112014011741A2 true BR112014011741A2 (pt) 2017-05-30

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014011741A BR112014011741A2 (pt) 2013-10-24 2014-01-13 método de redução de dor nas articulações induzida pelo exercício em mamíferos não artríticos

Country Status (14)

Country Link
US (1) US9066926B2 (https=)
KR (1) KR101664290B1 (https=)
AR (1) AR095104A1 (https=)
AU (1) AU2014202041B8 (https=)
BR (1) BR112014011741A2 (https=)
CA (1) CA2846644C (https=)
CL (1) CL2014001281A1 (https=)
CO (1) CO7020846A2 (https=)
IN (1) IN2014DE00193A (https=)
MX (1) MX347669B (https=)
MY (1) MY180106A (https=)
PH (1) PH12014501453B1 (https=)
SG (1) SG11201403524RA (https=)
WO (1) WO2015060888A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
AU2017325823A1 (en) * 2016-09-16 2019-05-02 Boston Scientific Neuromodulation Corporation System for pain management using heart sounds
AU2017334841B2 (en) 2016-09-27 2020-03-19 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
AU2017335497B2 (en) 2016-09-27 2020-01-16 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
EP3526007A4 (en) 2016-10-12 2020-05-27 Advanced Biomatrix, Inc. THREE-DIMENSIONAL (3D) PRINT INKS FROM NATURAL EXTRACELLULAR MATRIX MOLECULES
WO2018080887A1 (en) 2016-10-25 2018-05-03 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
WO2018132529A1 (en) 2017-01-11 2018-07-19 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
WO2018132535A1 (en) 2017-01-11 2018-07-19 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (zh) * 2017-02-28 2020-09-08 西安电子科技大学 一种多级搜索sage方法
CN107048412A (zh) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 一种含有ⅱ型胶原蛋白的咀嚼型产品
EP3936185A1 (en) 2017-07-18 2022-01-12 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
US20190054152A1 (en) 2017-08-21 2019-02-21 Lonza Inc. Composition and Nutritional Supplement Made Therefrom
WO2019046735A1 (en) 2017-08-31 2019-03-07 Lonza Inc. HEALTH PROMOTING COMPOSITION AND METHODS OF USING COMPLEMENT-RELATED APPLICATIONS
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
US20210290736A1 (en) * 2018-07-16 2021-09-23 Lonza Consumer Health Inc. Collagen and Cell Matter Supplement and Method for Administering Same
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
WO2021067452A1 (en) 2019-09-30 2021-04-08 Lonza Consumer Health Inc. Cannabinoid product for improving musculoskeletal health
WO2021154774A1 (en) * 2020-01-29 2021-08-05 Lonza Consumer Health Inc. Joint health composition and use thereof in healthy mammals
JP2023515867A (ja) 2020-03-03 2023-04-14 ロンザ・グリーンウッド・エルエルシー 食品および飲料用途での非変性ｉｉ型コラーゲンならびにその使用
MX2022010859A (es) 2020-03-24 2022-11-08 Lonza Greenwood Llc Colageno tipo ii sin desnaturalizar en alimentos y golosinas para animales.
EP4146251A1 (en) * 2020-06-12 2023-03-15 Lonza Greenwood LLC Undenatured type ii collagen as a supplement for improved endurance, lipid metabolism, and oxidative stress
EP4181947A1 (en) * 2020-08-19 2023-05-24 Lonza Consumer Health Inc. Method for improving inflammation, joint health, joint mobility, and joint comfort in healthy mammals
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
CN118215494A (zh) * 2021-11-12 2024-06-18 龙沙格林伍德有限公司 用于治疗骨骼关节的方法以及其组合物和用途
KR102771944B1 (ko) * 2023-09-25 2025-02-26 (주)온오퍼 고함량 액티브 성분을 갖는 반려동물용 츄 형태 영양제
WO2026006443A1 (en) * 2024-06-25 2026-01-02 Viscus Biologics, Llc Nutritional joint health supplement compositions and methods for making and using same
KR102923372B1 (ko) 2024-07-04 2026-02-05 씨엔에이바이오텍(주) 비변성 ⅱ형 콜라겐 제조방법 및 그의 제조방법에 따라 제조되는 비변성 ⅱ형 콜라겐

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
AU2800492A (en) 1991-11-08 1993-06-07 Gunilla Lofgren Nisser Partially occluded contact lens for treating visual and/or brain disorder
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (ja) 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
US20060062859A1 (en) 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
US20110218151A1 (en) 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
CN101822684B (zh) 2010-05-27 2012-08-15 江苏江山制药有限公司 用于防治骨关节痛的复方组合制剂及其制备方法
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (zh) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 一种骨关节保健组合物及其应用
CN103203012A (zh) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 关节保健品

Also Published As

Publication number Publication date
CO7020846A2 (es) 2014-08-11
CA2846644C (en) 2018-05-01
US20150119335A1 (en) 2015-04-30
PH12014501453A1 (en) 2015-01-21
CL2014001281A1 (es) 2015-10-30
KR101664290B1 (ko) 2016-10-11
AU2014202041B8 (en) 2020-04-02
WO2015060888A1 (en) 2015-04-30
AU2014202041A1 (en) 2015-05-14
MX2014002934A (es) 2015-09-21
PH12014501453B1 (en) 2015-01-21
SG11201403524RA (en) 2015-05-28
MX347669B (es) 2017-05-08
CA2846644A1 (en) 2015-07-13
US9066926B2 (en) 2015-06-30
MY180106A (en) 2020-11-23
IN2014DE00193A (https=) 2015-05-01
AR095104A1 (es) 2015-09-30
AU2014202041B2 (en) 2019-11-28
KR20150059132A (ko) 2015-05-29

Similar Documents

Publication Publication Date Title
BR112014011741A2 (pt) método de redução de dor nas articulações induzida pelo exercício em mamíferos não artríticos
IL290972A (en) Anti-vista antibodies and fragments
BR302013004875S1 (pt) Configuração aplicada em cigarro simulado
PL3804863T5 (pl) Sposób aplikacji i system aplikacji
FI20135175L (fi) Aktuaattori ja menetelmä aktuaattorin parantamiseksi
EP2988208A4 (en) METHOD AND DEVICE FOR SHARING APPLICATIONS
BR112015030934A2 (pt) Isolamento de construção
BR302013005965S1 (pt) Configuração aplicada em otomana
SG11201509326TA (en) Ship-type structure and method for designing ship-type structure
GB201319314D0 (en) Optimisation system and method
EP2985503A4 (en) JUNCTION STRUCTURE AND ITS JUNCTION METHOD
FI20135361L (fi) Analyyttinen menetelmä
BR302013005862S1 (pt) Configuração aplicada em coador
PL2969471T4 (pl) Sposób oraz wielofunkcyjny przyrząd do docinania
GB201302878D0 (en) Modified igG molecules
GB201316208D0 (en) Improvements in or relating to optimisation techniques
IL244148B (en) Cutting element and a method of cutting using the same
FI20140366L (fi) Menetelmä energiasisällön määrittämiseksi
FI20135648L (fi) Järjestely ja menetelmä massan tuottamiseksi
BR302013004676S1 (pt) Configuração aplicada em caixa de passagem
BR302013004677S1 (pt) Configuração aplicda em caixa de passagem
BR302013004678S1 (pt) Configuração aplicada em caixa de passagem
BR302013004679S1 (pt) Configuração aplicada em caixa de passagem
BR302013000817S1 (pt) Configuração aplicada em inserto
BR302013005268S1 (pt) Configuração aplicada em muleta axilar

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25D Requested change of name of applicant approved

Owner name: LONZA CONSUMER HEALTH INC. (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: LONZA CONSUMER HEALTH INC. (US)

B25A Requested transfer of rights approved

Owner name: CAPSUGEL MANUFACTURING, LLC (US)

B25D Requested change of name of applicant approved

Owner name: LONZA GREENWOOD LLC (US)